Latest news

4,996 article downloads per month. Click to see more open access visibility statistics. 

This journal has been accepted for indexing by Elsevier's highly regarded SCOPUS index

Journal newsletter sent to subscribers in week 28, 2009. Register to receive future newsletters.

Journal newsletter sent to subscribers in week 20, 2009. Register to receive future newsletters.

New call for papers sent to newsletter subscribers in week 7 2009. Readers who wish to be elligible to receive CFPs should subscribe to the newsletter.

This journal has been accepted for indexing by Elsevier's highly regarded SCOPUS index

Clinical Medicine: Blood Disorders accepted for indexing by DOAJ

Journal overview

Aims and scope:

Clinical Medicine Insights: Blood Disorders is an international, open access, peer reviewed journal which considers manuscripts on all aspects of the diagnosis, management and prevention of blood disorders, in addition to related genetic, pathophysiological and epidemiological topics.

Former title:

Prior to 1/1/2010 this journal was titled Clinical Medicine: Blood Disorders (ISSN 1178-2269.) 

Editorial standards and procedures:

Submissions, excluding editorials, letters to the editor and dedications, will be peer reviewed by two reviewers.  Reviewers are required to provide fair, balanced and constructive reports.  

Under our Fairness in Peer Review Policy authors may appeal against reviewers' recommendations which are ill-founded, unobjective or unfair.  Appeals are considered by the Editor in Chief or Associate Editor.

Papers are not sent to peer reviewers following submission of a revised manuscript. Editorial decisions on re-submitted papers are based on the author's response to the initial peer review report.

Indexing:

This journal is indexed by the following services:

• Google Scholar
• CAS
• DOAJ
• SCOPUS
• Embase
• OAIster
  

National Institutes of Health Public Access Policy compliant:

As of April 7 2008, the US NIH Public Access Policy requires that all peer reviewed articles resulting from research carried out with NIH funding be deposited in the Pubmed Central archive.

If you are an NIH employee or grantee Libertas Academica will ensure that you comply with the policy by depositing your paper at Pubmed Central on your behalf. 

Information for authors

Call for papers:

The Editor in Chief welcomes submissions.  Submissions of the following types are invited:

• Original research articles.
• Reviews: comprehensive, authoritative, descriptions of any subject within the journal's scope. They may cover basic science and clinical reviews, ethics, pro/con debates, and equipment reviews.
• Commentaries: focused and opinionated articles on any subject within the journal's scope. These articles are usually related to a contemporary issue.
• Hypotheses: articles that present an original hypothesis backed solely by previously published results rather than any new evidence. They should outline significant progress in thinking that would also be testable.
• Letters to the Editor: these can be either a re-analysis of a previously published article, or a response to such a re-analysis from the authors of the original publication.
• Methodology articles: these discuss a new experimental method, test or procedure. The article must describe a demonstrable advance on what is currently available. The method needs to have been well tested and ideally, but not necessarily, used in a way that proves its value.
• Short reports: brief reports of data from original research.
• Meeting reports: a report pertaining to activity at a meeting or conference Articles published in this journal are immediately available without delay upon publication and enjoy substantial visibility.
  
• Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction. Case reports must meet appropriate ethical standards.

All submissions are subject to prompt, objective and fair peer review in compliance with our Fairness in Peer Review Policy.  Copyright in published articles remains with the author(s).  Authors are continually informed of the progress of their paper and our staff are friendly and responsive. 

One author recently wrote: "I would like to say that this is the most author-friendly editing process I have experienced in over 150 publications. Thank you most sincerely."

Criteria for publication: 

Publication is dependent on peer reviewers' judgement of papers.  Reviewers are asked to provide thoughtful and unbiased feedback to authors to ensure that the conclusions of papers are valid and manuscripts achieve reasonable standards of scholarliness and intelligibility. 

Previous work in the field must be acknowledged and papers should read without unreasonable difficulty.  Papers should fit comfortably within the scope of the journal.

Reviewers are asked to act in a fair, objective and constructive manner which maintains quality standards and helps authors to communicate their research.  They are instructed that in areas of genuinely novel research issues may be raised which cannot immediately be resolved and that absolutely rigorous validation of data may therefore not be possible. 

More information on the role of peer reviewers is available on the information for reviewers page.  Where authors consider that reviewers have made recommendations which are unreasonable, unobjective or ill-founded they may appeal them to the Editor in Chief or Associate Editor under our Fairness in Peer Review Policy.

Articles submitted to other journals:

We are willing to consider papers which have been peer reviewed by other journals but not accepted for publication. 

Services for authors:

Prior to peer review of your paper we can:

• Have your paper's reference style revised to meet our requirements,
• Have your paper's English revised by specialist English-speaking technical editors.

After peer review of your paper we can:

• Have your paper revised in accordance with peer reviewer's recommendations and have a summary of responses to the reviewers created by our specialist external substantive editors,
• Provide bound reprints of your article in colour or black and white ,
• Provide online-early rapid publication if your paper prior to typesetting.

What other authors have said:

Libertas Academica actively requests, receives and acts upon feedback from authors, readers and editorial boards.  Here's what some recent authors have said about us:

"Within a couple of days the reviewers had been procured and the manuscript was out."

"The communication between your staff and me has been terrific.  Whenever progress is made with the manuscript, I receive notice.  Quite honestly, I've never had such complete communication with a journal."

"LA is different, and hopefully represents a kind of scientific publication machinery that removes the hurdles from free flow of scientific thought."

Article processing fees:

All submissions to this journal are subject to an article processing fee if they are accepted for publication.  Article processing fees are used to fund the processing of your paper and development of the journal.  Article processing fees are the only compulsory charge you will face and do not vary according to word count, page count, colour figures or any other factor.  There is no additional charge for the author(s) to make any use of their article and no charge to readers to access it.

Full fee waivers are available for authors working in undeveloped nations and partial discounts of 20-50% are available to authors in other nations.  Authors must be able to verifiably demonstrate their suitability for a discount or waiver.  Availability of waivers and discounts is subject to monthly availability and is given at the publisher's discretion.  Waivers and discounts must be applied for prior to submission.  Neither are available after submission.

Register as a peer reviewer:

Do you wish to register as a peer reviewer?  Or are you already a registered peer reviewer but you need to update your contact details?   To register or update your details visit the peer reviewer registration form. 

Applicants must be able to demonstrate at least five years of continuous experience in the journal's subject area including at least two in the previous 24 months.

Editor in Chief profile

Editorial Board

Seth L. Alper, MD, PhD
Professor of Medicine, Harvard Medical School, Department of Medicine, Molecular and Vascular Medicine Unit and Renal Division, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA

George F. Atweh, PhD
Lillian and Henry Stratton Professor of Medicine, Chief, Division of Hematology/Oncology, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA

M. A. Bender, MD, PhD
Associate Professor, Pediatrics, Division of Hematology/Oncology, University of Washington, Seattle, Washington, USA

Ronald T Brown, PhD
Professor and Dean, Department of Public Health, Temple University, Philadelphia, Pennsylvania, USA

Alan B. Cantor, PhD
Assistant Professor of Pediatrics, Division of Pediatric Hematology-Oncology, Children's Hospital Boston and the Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Michael Cappello, MD
Professor of Pediatrics, Microbial Pathogenesis, and Epidemiology & Public Health, Director, Program in International Child Health, Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA

Marc T. Hamilton, PhD
Associate Professor, Biomedical Sciences, College of Veterinary Medicine, University of Missouri, Columbia, Missouri, USA

Paul Curtis Hendrie, MD, PhD
Professor, Pennington Biomedical Research Center, Baton Rouge, LA, USA
Clinical Assistant Professor, Hematology Division, Department of Medicine, Univeristy of Washington, Seattle, Washington, USA

Adam Nathan Goldfarb, PhD
Associate Professor, Pathology, University of Virginia School of Medicine, Charlottesville, Virginia, USA

Abdel Rahim A Hamad, PhD
Assistant Professor of Pathology, Assistant Professor of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA

Jacqueline M. Hibbert, PhD
Associate Professor, Biochemistry Division, Microbiology/Biochemistry/ Immunology Department, Morehouse School of Medicine, Atlanta, Georgia, USA

Rodney J. Y. Ho, PhD
Professor and Associate Dean for Research and New Initiatives, Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington, USA

Dhananjay K. Kaul, PhD
Professor, Medicine, Division of Hematology, Albert Einstein College of Medicine, Bronx, New York, USA

Delong Liu, MD, PhD
Associate Professor of Medicine, Division of Oncology /Hematology, New York Medical College, Director, Mini-Allogeneic Stem Cell Transplantation Program Westchester Medical Center Chief of Hematology Phelps Memorial Hospital Munger Pavilion, New York, USA

Clifford A. Lowell, MD, PhD
Professor and Chair, Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California, USA

Naomi L. C. Luban, MD
Chief, Laboratory Medicine & Pathology, Director, Transfusion Medicine/The Edward J. Miller Donor Center, Senior Attending, Hematology-Oncology, Associate Program Director of the Pediatric Clinical Research Center, Children's National Medical Center, Vice Chair for Academic Affairs, Department of Pediatrics, Professor, Pediatrics and Pathology, The George Washington University Medical Center, Department of Laboratory Medicine, Children’s National Medical Center, Washington, District of Columbia, USA

John Meletis, MD, PhD
Professor in Medicine and Hematology, First Department of Internal Medicine, University of Athens School of Medicine, Athens, Greece

Mortimer Poncz, MD
Children's Hospital of Philadelphia, Chief, Division of Hematology, Philadelphia, Pennsylvania, USA

Pavan Reddy, PhD
Professor of Medicine, University of Michigan, Hematology-Oncology, Blood and Marrow Transplantation Program, University of Michigan Medical Center, Ann Arbor, Michigan, USA

Robert L. Redner, MD
Associate Professor of Medicine, Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh and the University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, USA

Paola Sebastiani, PhD
Associate Professor, Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA

Martha Sola-Visner, MD
Assistant Professor of Pediatrics, Harvard University School of Medicine, Division of Newborn Medicine, Children's Hospital Boston, Boston, Massachusetts, USA

Join an editorial board or update your details:

Related journals